Vigabatrin caused rapidly progressive deterioration in two cases with early myoclonic encephalopathy associated with nonketotic hyperglycinemia

Journal of Child Neurology

Volumn 21, Issue 1, 2006, Pages 82-84

  Tekgul, Hasan ^a   Serdaroǧlu, Gul ^a,b   Karapinar, Bulent ^a   Polat, Muzaffer ^a   Yurtsever, Serap ^a   Tosun, Ayşe ^a   Coker, Mahmut ^a   Gokben, Sarenur ^a  

^a University Medical School   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; DEXTROMETHORPHAN; GLYCINE; VIGABATRIN;

ACUTE BRAIN DISEASE; AMINO ACID BLOOD LEVEL; AMINO ACID BRAIN LEVEL; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; BRAIN SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; DETERIORATION; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCINEMIA; INFANT; INFANTILE SPASM; MUSCLE HYPOTONIA; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RESPIRATORY ACIDOSIS; RESPIRATORY FAILURE; SOMNOLENCE; TREATMENT OUTCOME;

ANTICONVULSANTS; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; FATAL OUTCOME; FEMALE; HUMANS; HYPERGLYCINEMIA, NONKETOTIC; INFANT; MAGNETIC RESONANCE SPECTROSCOPY; SEIZURES; TIME FACTORS; VIGABATRIN;

EID: 33646879987     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738060210011801     Document Type: Article

References (15)

1. Ohtahara S: Clinico-electrical delineation of epileptic encephalopathies in childhood. Asian Med J 1978;21:7-17.
2. Murakami N, Ohtsuku Y, Ohtahara S: Early infantile epileptic syndromes with suppression bursts: Early myoclonic encephalopathy vs. Ohtahara's syndrome. Jpn J Psychiatry Neurol 1993;47:197-200.
3. Tada K, Kure S: Non-ketotic hyperglycinaemia: Molecular lesion, diagnosis and pathophysiology. J Inherit Metab Dis 1993;16:691-703.
4. Boney A, Degani Y, Harari M: Prognostic clues and outcome of early treatment of nonketotic hyperglycinemia. Pediatr Neurol 1996;15:137-141.
5. Lombroso CT: Early myoclonic encephalopathy, early infantile epileptic encephalopathy, and benign and severe infantile myoclonic epilepsies: A critical review and personal contributions. J Clin Neurophysiol 1990;7:380-408.
6. Baxter PS, Gardner-Medwin D, Barwick DD, et al: Vigabatrin monotherapy in resistant neonatal seizures. Seizure 1995;4:57-59.
7. Meldrum BS: GABAergic mechanisms in the pathogenesis and treatment of epilepsy. Br J Clin Pharmacol 1989;27(Suppl 1):3-11.
8. Mumford J, Dulac O: Yigabatrin: A new antiepileptic medication. J Child Neurol 1991;6(Suppl 2):3-5.
9. Wong IC, Lhatoo SD: Adverse reactions to new anticonvulsant drugs. Drug Saf 2000;23:35-56.
10. Haas-Lude K, Wolff M, Riethmuller J, et al: Acute encephalopathy associated with vigabatrin in a six-month old girl. Epilepsia 2000;41:628-630.
11. Sharief MK, Sander JW, Shorvon SD: Acute encephalopathy with vigabatrin. Lancet 1993;342:619.
12. Salke-Kellermann A, Baier H, Rambeck B, et al: Acute encephalopathy with vigabatrin. Lancet 1993;342:185.
13. Garcia PA, Garcia-Zarza E, Peraita AR: Acute encephalopathy and myoclonic status induced by vigabatrin monotherapy. Neurologia 2000;15:370-374.
14. Lortie A, Chiron C, Dumas C, et al: Optimizing the indication of vigabatrin in children with refractory epilepsy. J Child Neurol 1997;12:253-259.
15. Huisman TA, Thiel T, Steinmann B, et al: Proton magnetic resonance spectroscopy of the brain of a neonate with nonketotic hyperglycinemia: In vivo-in vitro (ex vivo) correlation. Eur Radiol 2002;12:858-861.